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Case Report
Introduction
Primary spontaneous bacterial peritonitis (SBP) is a recognized 
cause of morbidity and mortality in cirrhotic patients. SBP is an 
acute bacterial infection of the ascites fluid and is known to 
affect patients with cirrhosis from any cause, including alco-
holic cirrhosis.1,2 The pathophysiology of bacterial introduction 
in the ascitic fluid is not known; however, cirrhosis predisposes 
the development of gastrointestinal bacterial overgrowth and 
increased intestinal permeability.3,4 Enterobacteriaceae have 
been isolated from the majority of peritonitis cases, and the 
gram-negative aerobe Escherichia coli is the most commonly 
isolated organism.3,4 While Enterobacteriaceae are commonly 
encountered, gram-positive organisms such as streptocococi 
and enterococci are sometimes found. Anaerobic organisms are 
rare because of the high oxygen tension in ascetic fluid.3-5 
However, there are reports of anaerobic SBP infections. We 
report the case of a patient with a history of alcoholic cirrhosis 
who developed SBP and concurrent bacteremia with the anaer-
obe Clostridium tertium.
Case Report
A 60-year-old man was admitted with worsening abdominal 
pain, nausea, vomiting, fever, and grossly extended abdomen 
accompanied by 1+ bilateral lower extremity edema. His 
symptoms had been ongoing for 1 week. Contributory medical 
history was significant for alcoholic cirrhosis and umbilical 
hernia surgery approximately 2 months prior to current admis-
sion. Temperature on admission was 102.2°F, otherwise his 
vitals were stable with no signs of sepsis or hemodynamic 
instability. Abdominal exam revealed diffuse tenderness and 
positive fluid thrill. His only subjective complaint was pain. 
Laboratory findings on admission are listed in Table 1, with 
abnormalities including serum white blood cell count and 
albumin. The patient’s cirrhosis severity was rated as a Child-
Pugh Class B. Initial paracentesis fluid study results are listed 
in Table 2. The patient’s urinalysis was negative and nondiag-
nostic. Empiric antibiotic therapy was initiated with intrave-
nous (IV) cefotaxime. The antibiotics were subsequently 
changed to IV vancomycin and meropenem due to persistent 
fever and abdominal pain. A repeat ultrasound-guided para-
centesis was conducted on day 4 of admission, with 2 liters of 
fluid removed. Ascitic fluid cultures grew out anaerobic gram-
positive rods. On day 5, the organism was identified as C ter-
tium by matrix-assisted laser desorption/ionization-time of 
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Figure 1. Gram stain of Clostridium tertium, which is an 
anaerobic, motile, gram-positive bacterium. It is easily decolorized 
in gram-stained smears and can be mistaken for a gram-negative 
organism.
flight (MALDI-TOF) mass spectrometry. Following isolation 
of the anaerobic organism, ciprofloxacin and metronidazole 
were added to the vancomycin pending susceptibility testing 
and meropenem was discontinued. Over the next 24 hours, the 
patient improved clinically, with defervescence and leukocy-
tosis resolution. Repeat cultures on day 7 were negative. 
Susceptibility testing was conducted using E-test, which 
showed that the C tertium was sensitive to vancomycin, cipro-
floxacin, trimethoprim/sulfamethoxazole, meropenem, and 
clindamycin. IV antibiotics were continued until repeat cul-
tures were finalized as negative, and the patient was discharged 
on oral ciprofloxacin.
Discussion
Clostridium tertium is a ubiquitous gram-positive bacillus iso-
lated in soil and the gastrointestinal tract. C tertium distinguishes 
itself among the clostridia as a non–toxin-producing, aerotoler-
ant species.5 Typically, C tertium does not have pathogenic 
potential, and its role as a human pathogen is uncertain.6,7 
Infection with the organism has been rare after initial descrip-
tion in 1917. However, C tertium has documented cases of SBP, 
intraabdominal infection, enterocolitis, meningitis, septic arthri-
tis, pneumonia, and necrotizing fasciitis.5-13 Case reports have 
identified neutropenia, mucosal injury, β-lactam antibiotics 
(third-generation cephalosporins), cytotoxic chemotherapy, and 
severe liver disease as predisposing factors for C tertium  
infection.5 While scare, case reports document that C tertium is 
a cause of SBP. Our case report of a patient with alcoholic cir-
rhosis adds to the literature regarding C tertium SBP. Previously 
published case reports include the following:
•• Butler and Pitt reported a case of C tertium SBP in a 
42-year-old female with a history of cirrhosis.8 The 
patient was admitted for management of hepatic 
encephalopathy with subsequent development of peri-
tonitis. Clinical and microbiological cure was 
achieved with the cephamycin antibiotic cefoxitin.
•• Miller et al reported 32 cases of C tertium bacteremia 
over a 7-year span.5 All 32 patients presented with 
fever, 59% had one or more abdominal symptoms, 9 
had diarrhea (including 5 with a positive test for 
Clostridium difficile toxin), 9 had abdominal pain, 5 
had nausea, and 1 had constipation. Twenty-nine of 
the 32 cases involved neutropenic patients, all of 
which were status post chemotherapy within 9 to 21 
Table 1. Laboratory Results Upon Admission.
Parameters Readings Normal Ranges
White cell count 15.2 3.6-11.1 K/mm3
Hemoglobin 13.9 12.9-16.1 g/dL
Platelet 196 165-353 K/mm3
Sodium 137 135-145 mmol/L
Potassium  3.5 3.5-5.1 mmol/L
Blood urea nitrogen 22 7-26 mg/dL
Creatinine  1.1 0.5-1.3 mg/dL
Calcium  9.0 8.4-10.2 mg/dL
Albumin  2.7 3.5-5.0 g/dL
Total bilirubin  5.6 0.2-1.2 mg/dL
Alkaline phosphatase 105 40-150 U/L
Alanine aminotransferase 44 0-55 U/L
Aspartate aminotransferase 74 5-34 U/L
International normalized ratio  1.4 0.8-1.2
Table 2. Paracentesis Fluid Studies.
Parameters Readings
Total cells 23 777 cells/mm3
Nucleated cells 15 707 cells/mm3
Polymorphonuclear leukocytes 84%
Absolute polymorphonuclear leukocytes 13 193 cells/mm3
Lymphocytes 9%
Red blood cells 8064 cells/mm3
Total protein 1.6 g/dL
Sutton et al 3
days before the onset of C tertium bacteremia. The 3 
nonneutropenic patients had underlying host factors 
disposing them to C tertium infection: (1) chronic 
alcoholism and end-stage liver disease, (2) systemic 
lupus erythematosus receiving high-dose corticoste-
roids and recent placement of a percutaneous gastros-
tomy tube, and (3) Crohn’s disease. Four patients died 
within 1 week after the isolation of C tertium, includ-
ing the patient with SBP. The patient with SBP was a 
43-year-old patient with end-stage liver disease with 
concurrent bacteremia.
•• Victor and Opal reported 43 patients with SBP during 
a 5-year period.10 Alcoholic liver disease was the 
underlying cause in 72% of the cases, and 
Enterobacteriaceae accounted for 66% of the cases. 
There were 2 cases of anaerobic infections (one 
patient had C tertium SBP with concurrent bactere-
mia). The overall mortality rate was 65% (mortality 
rates were not discussed regarding individual cases).
These case reports demonstrate that C tertium is a rare cause 
of SBP. However, C tertium is often mistaken for Bacillus or 
Lactobacillus species because of its micromorphology and 
growth pattern (Figure 1), which could lead to underdiagno-
ses.14-16 Therefore, thorough identification of this species is 
critical. Unfortunately, traditional identification of anaerobes 
is time-consuming and cumbersome. New methods based on 
mass spectrometry such as MALDI-TOF mass spectrometry, 
which have been developed for the rapid identification of 
bacterial strains, can offer new possibilities for identifica-
tion.15,16 Our case report is unique as we identified C tertium 
by MALDI-TOF. The appropriate identification of the organ-
ism allowed for early identification and susceptibility tests to 
be ordered. Ultimately, the bacterial identification allowed 
for targeted antibiotic therapy. Targeted therapy is critical for 
C tertium because in contrast to other clostridial species, 
treatment can be a challenge.5,15,16 Although studies evaluat-
ing sufficient numbers of strains are lacking, C tertium 
exhibits resistance to various antibiotics including third- and 
fourth-generation cephalosporins. Additionally, our article is 
unique in that we performed e-testing to evaluate the suscep-
tibility of C tertium to select antibiotics. The organism was 
susceptible to vancomycin, ciprofloxacin, sulfamethoxazole/
trimethoprim, meropenem, and clindamycin (Figure 2).
Clostridium tertium’s sporadic presence as an infectious 
pathogen in SBP can make treatment decisions difficult and 
lead to inappropriate antibiotics. Four characteristics of C 
tertium make it a clinically important bacterium worthy of 
consideration in evaluating SBP patients: (1) antibiotic resis-
tance, (2) aerotolerant nature and difficulty in identification, 
(3) human commensal, and (4) potential to cause mortality. C 
tertium exhibits resistance to several antibiotics including 
antibiotics recommended for empiric therapy for SBP.5 C 
tertium is often resistant to clindamycin, metronidazole, and 
cephalosporins; however, the C tertium identified in our case 
report was susceptible to clindamycin. For SBP patients 
empirically treated with guideline-recommended antibiotics, 
clinical monitoring is highly recommended to suspect 
Figure 2. E-test of select antibiotics tested against Clostridium tertium. E-testing was performed to evaluate the susceptibility of C tertium 
to select antibiotics. The organism was susceptible to vancomycin, ciprofloxacin, sulfamethoxazole/trimethoprim, meropenem, and 
clindamycin.
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alternative etiologic organisms.17 In our patient, antibiotics 
were selected based on expected etiology (eg, Escherichia 
coli); however, once our patient did not respond clinically, 
antibiotics were adjusted. Second, C tertium is aerotolerant, 
allowing the bacterium to survive the oxygen-rich environ-
ment of the ascitic fluid.5,10 It also provides C tertium the 
ability to grow morphologically distinct features under aero-
bic versus anaerobic conditions.15,16 When cultured under 
aerobic conditions, C tertium was initially identified as a 
Lactobacillus species in a case report, and only under careful 
anaerobic conditions was the proper bacterium identified.14 
This oftentimes leads to false identification and delay in 
proper antibiotic treatment. The introduction of MALDI-
TOF for the rapid identification of bacterial pathogens may 
be particularly helpful in this group of organisms. Third is C 
tertium’s presence as a normal commensal of the gastrointes-
tinal tract. This, coupled with gastrointestinal abnormalities 
or immunosuppression, may set the stage for potential over-
growth and infection.5 Finally, C tertium is associated with 
mortality. Of the 4 case reports currently existing of C ter-
tium SBP, one patient had died, two responded to therapy, 
and one is unknown. C tertium causing other types of infec-
tions has also demonstrated a mortality potential. While the 
majority of C tertium cases are associated with patients with 
neutropenia, there are cases demonstrating that C tertium is 
an important cause in a non-neutropenic patient.5,8,10,13
Conclusion
This is a unique case of C tertium SBP and bacteremia in a 
patient with alcoholic cirrhosis. The patient was successfully 
treated with intravenous antibiotics and was discharged home 
on oral ciprofloxacin. The goal of this case report is to draw 
attention to the infectious potential of C tertium. Additionally, 
this case report is unique in that it is the fourth documented C 
tertium SBP case, utilized MALDI-TOF for identification, and 
susceptibility testing for select antibiotics was performed.
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